Arielle Bensimon

Vice President
Arielle Bensimon


Ph.D., health policy, Harvard University; B.A., economics, government, and English, Cornell University

Summary of Experience

Dr. Bensimon specializes in health economics and outcomes research (HEOR) and provides expertise in decision modeling methods for health technology appraisal. She has led the design and implementation of cost-effectiveness and budget impact models in multiple countries, guided the development of several successful regulatory submissions to the UK’s National Institute for Health and Care Excellence (NICE) and Canada’s Drug and Health Technology Agency (CADTH), and closely supported clients throughout the ICER review process in the US. Her work has also included empirical comparative effectiveness studies using large retrospective databases and medical chart reviews, burden-of-illness studies, development of predictive models to estimate health risks, patient-reported outcome (PRO) studies, and analyses of clinical trial data to address a variety of research objectives. Dr. Bensimon has conducted research in a range of therapeutic areas, including oncology indications, diabetes, hypertension, mental health disorders, rare hereditary diseases, and several infectious diseases and autoimmune disorders. Her work has been presented at clinical and economic research conferences and published in various peer-reviewed journals.